Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA Q-PCR REAGENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 DETECTION TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRIAL INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER'S FIVE FORCES MODEL
6 NORTH AMERICA Q-PCR REAGENTS MARKET: REGULATIONS
6.1 REGULATION IN U.S
6.2 REGULATION IN EUROPE
6.3 REGULATION IN SINGAPORE
6.4 REGULATION IN AUSTRALIA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN CHRONIC DISEASES AND COMMUNICABLE DISEASES
7.1.2 INCREASE IN GERIATRIC POPULATION
7.1.3 INCREASE IN EARLY DIAGNOSIS RATE
7.1.4 INCREASE IN ADVANCED TECHNOLOGY
7.2 RESTRAINTS
7.2.1 STRINGENT RULES & REGULATIONS
7.2.2 HIGH COST OF PRODUCT
7.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
7.2.4 ADVANCEMENT IN FIELD OF GENOMICS
7.3 OPPORTUNITIES
7.3.1 RISE IN GOVERNMENT FUNDING FOR HEALTHCARE
7.3.2 RISE IN HEALTHCARE EXPENDITURE
7.4 CHALLENGES
7.4.1 LACK OF SKILLED WORKFORCE
7.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS
8 IMPACT OF COVID-19 ON THE NORTH AMERICA Q-PCR REAGENTS MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS BY MANUFACTURERS
8.5 CONCLUSION
9 NORTH AMERICA Q-PCR REAGENTS MARKET, BY DETECTION TYPE
9.1 OVERVIEW
9.2 DYE-BASED REAGENTS
9.2.1 MASTER MIX
9.2.2 PRIMERS
9.2.3 DNA TEMPLATE
9.3 PROBE-BASED REAGENTS
9.3.1 MASTER MIX
9.3.2 PRIMERS
9.3.3 DNA TEMPLATE
10 NORTH AMERICA Q-PCR REAGENTS MARKET, BY ASSAY TYPE
10.1 OVERVIEW
10.2 QPCR SINGLEPLEX TEST/ASSAY
10.3 QPCR MULTIPLEX TEST/ASSAY
11 NORTH AMERICA Q-PCR REAGENTS MARKET, BY PLEXITY
11.1 OVERVIEW
11.2 DYE-BASED REAGENTS
11.2.1 SINGLEPLEX
11.2.2 MULTIPLEX
11.3 PROBE-BASED REAGENTS
11.3.1 SINGLEPLEX
11.3.2 MULTIPLEX
12 NORTH AMERICA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE
12.1 OVERVIEW
12.2 KITS
12.3 MASTER MIXERS
13 NORTH AMERICA Q-PCR REAGENTS MARKET, BY TECHNOLOGY
13.1 OVERVIEW
13.2 GENE EXPRESSION
13.3 GENE TYPING
13.4 MIRNA ANALYSIS
13.5 PRE-AMPLIFICATION
13.6 VIRUS DETECTION
14 NORTH AMERICA Q-PCR REAGENTS MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 RESEARCH
14.3 DIAGNOSTICS
14.4 FORENSIC
15 NORTH AMERICA Q-PCR REAGENTS MARKET, BY END USER
15.1 OVERVIEW
15.2 RESEARCH & ACADEMIC INSTITUTE
15.3 HOSPITAL AND DIAGNOSTIC CENTERS
15.4 CLINICAL RESEARCH ORGANIZATION
15.5 FORENSIC LABORATORIES
15.6 OTHERS
16 NORTH AMERICA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 THIRD PARTY DISTRIBUTORS
16.4 OTHERS
17 NORTH AMERICA Q-PCR REAGENTS MARKET, BY REGION
17.1 NORTH AMERICA
17.1.1 U.S.
17.1.2 CANADA
17.1.3 MEXICO
18 NORTH AMERICA Q-PCR REAGENTS MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
19 NORTH AMERICA Q-PCR REAGENTS MARKET: SWOT ANALYSIS
20 COMPANY PROFILE
20.1 F. HOFFMANN-LA ROCHE LTD
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 PRODUCT PORTFOLIO
20.1.4 RECENT DEVELOPMENT
20.2 MERCK KGAA
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 PRODUCT PORTFOLIO
20.2.4 RECENT DEVELOPMENTS
20.2.4.1 PARTNERSHIP
20.2.4.2 NEW LABORATORY FACILITY
20.2.4.3 NEW DISTRIBUTION CENTER
20.3 THERMO FISHER SCIENTIFIC INC
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENTS
20.3.4.1 ACQUISITION
20.3.4.2 PRODUCT LAUNCH
20.4 AGILENT TECHNOLOGIES, INC
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 RECENT DEVELOPMENTS
20.4.4.1 DISTRIBUTION AGREEMENT
20.4.4.2 PRODUCT LAUNCH
20.5 SEEGENE INC.
20.5.1 COMPANY SNAPSHOT
20.5.2 PRODUCT PORTFOLIO
20.5.3 RECENT DEVELOPMENT
20.6 BIONEER CORPORATION
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 BIO-RAD LABORATORIES, INC.
20.7.1 COMPANY SNAPSHOT
20.7.2 REVENUE ANALYSIS
20.7.3 PRODUCT PORTFOLIO
20.7.4 RECENT DEVELOPMENTS
20.7.4.1 PARTNERSHIP
20.7.4.2 AWARD
20.8 BIOTIUM
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENTS
20.9 EMPIRICAL BIOSCIENCE, INC.
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.9.3.1 EUA AUTHORISATION
20.9.3.2 ISO CERTIFICATION
20.9.3.3 PRODUCT LAUNCH
20.1 ENZO BIOCHEM INC
20.10.1 COMPANY SNAPSHOT
20.10.2 REVENUE ANALYSIS
20.10.3 PRODUCT PORTFOLIO
20.10.4 RECENT DEVELOPMENT
20.11 GENEDIREX, INC
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENT
20.12 KANEKA EUROGENTEC S.A
20.12.1 COMPANY SNAPSHOT
20.12.2 REVENUE ANALYSIS
20.12.3 PRODUCT PORTFOLIO
20.12.4 RECENT DEVELOPMENT
20.13 MIRXES PTE LTD
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 NORGEN BIOTEK CORP
20.14.1 COMPANY SNAPSHOT
20.14.2 PRODUCT PORTFOLIO
20.14.3 RECENT DEVELOPMENT
20.15 NEW ENGLAND BIOLABS
20.15.1 COMPANY SNAPSHOT
20.15.2 PRODUCT PORTFOLIO
20.15.3 RECENT DEVELOPMENTS
20.15.3.1 AQUISITION
20.15.3.2 PRODUCT LAUNCH
20.15.3.3 SUBSIDIARY
20.16 PCR BIOSYSTEMS
20.16.1 COMPANY SNAPSHOT
20.16.2 PRODUCT PORTFOLIO
20.16.3 RECENT DEVELOPMENT
20.17 PROMEGA CORPORATION
20.17.1 COMPANY SNAPSHOT
20.17.2 PRODUCT PORTFOLIO
20.17.3 RECENT DEVELOPMENT
20.18 QIAGEN
20.18.1 COMPANY SNAPSHOT
20.18.2 REVENUE ANALYSIS
20.18.3 PRODUCT PORTFOLIO
20.18.4 RECENT DEVELOPMENTS
20.18.4.1 NEW FACILITY
20.18.4.2 ACQUISITION
20.19 QUANTABIO
20.19.1 COMPANY SNAPSHOT
20.19.2 PRODUCT PORTFOLIO
20.19.3 RECENT DEVELOPMENTS
20.19.3.1 CONFERENCE
20.19.3.2 PRODUCT LAUNCH
20.2 SINO BIOLOGICAL INC.
20.20.1 COMPANY SNAPSHOT
20.20.2 PRODUCT PORTFOLIO
20.20.3 RECENT DEVELOPMENT
20.21 SOLIS BIODYNE
20.21.1 COMPANY SNAPSHOT
20.21.2 PRODUCT PORTFOLIO
20.21.3 RECENT DEVELOPMENT
20.22 TAKARA HOLDINGS INC
20.22.1 COMPANY SNAPSHOT
20.22.2 REVENUE ANALYSIS
20.22.3 PRODUCT PORTFOLIO
20.22.4 RECENT DEVELOPMENTS
20.22.4.1 MANUFACTURING UNIT
20.22.4.2 ISO CERTIFICATION
20.23 TONBO BIOSCIENCES
20.23.1 COMPANY SNAPSHOT
20.23.2 PRODUCT PORTFOLIO
20.23.3 RECENT DEVELOPMENT
20.24 TRANSGENE BIOTEK LIMITED
20.24.1 COMPANY SNAPSHOT
20.24.2 REVENUE ANALYSIS
20.24.3 PRODUCT PORTFOLIO
20.24.4 RECENT DEVELOPMENT
20.25 YOUSEQ LTD
20.25.1 COMPANY SNAPSHOT
20.25.2 PRODUCT PORTFOLIO
20.25.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
List of Table
TABLE 1 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 2 NORTH AMERICA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA QPCR SINGLEPLEX TEST/ASSAY IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA QPCR MULTIPLEX TEST/ASSAY IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA KITS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA MASTER MIXERS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA GENE EXPRESSION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA GENE TYPING IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA MIRNA ANALYSIS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA PRE-AMPLIFICATION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA VIRUS DETECTION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA GENE EXPRESSION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA DIAGNOSTICS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA FORENSIC IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA RESEARCH & ACADEMIC INSTITUTE IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA HOSPITAL AND DIAGNOSTIC CENTERS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA CLINICAL RESEARCH ORGANIZATION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA FORENSIC LABORATORIES IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA OTHERS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA DIRECT TENDER IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA OTHERS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA Q-PCR REAGENTS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 U.S. Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 52 U.S. DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 53 U.S. PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 54 U.S. Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 55 U.S. Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 56 U.S. DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 57 U.S. PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 58 U.S. Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 59 U.S. Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 60 U.S. Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 61 U.S.Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 62 U.S. Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 63 CANADA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 64 CANADA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 65 CANADA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 66 CANADA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 67 CANADA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 68 CANADA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 69 CANADA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 70 CANADA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 71 CANADA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 72 CANADA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 73 CANADA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 74 CANADA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 75 MEXICO Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)
TABLE 76 MEXICO DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 77 MEXICO PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 78 MEXICO Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)
TABLE 79 MEXICO Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 80 MEXICO DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 81 MEXICO PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)
TABLE 82 MEXICO Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)
TABLE 83 MEXICO Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 84 MEXICO Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 85 MEXICO Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 86 MEXICO Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA Q-PCR REAGENTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA Q-PCR REAGENTS MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA Q-PCR REAGENTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA Q-PCR REAGENTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA Q-PCR REAGENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA Q-PCR REAGENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA Q-PCR REAGENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA Q-PCR REAGENTS MARKET: APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA Q-PCR REAGENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA Q-PCR REAGENTS MARKET: SEGMENTATION
FIGURE 11 INCREASE IN DEMAND FOR Q-PCR REAGENTS IS EXPECTED TO DRIVE THE NORTH AMERICA Q-PCR REAGENTS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 MODERATE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA Q-PCR REAGENTS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF Q-PCRREAGENTS MARKET
FIGURE 14 PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN WORLD HEALTH ORGANISATION (WHO) REGIONS IN 2020
FIGURE 15 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE, 2021
FIGURE 16 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE, 2020-2029 (USD MILLION)
FIGURE 17 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE, CAGR (2022-2029)
FIGURE 18 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA Q-PCR REAGENTS MARKET: BY ASSAY TYPE, 2021
FIGURE 20 NORTH AMERICA Q-PCR REAGENTS MARKET: BY ASSAY TYPE, 2020-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA Q-PCR REAGENTS MARKET: BY ASSAY TYPE, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA Q-PCR REAGENTS MARKET: BY ASSAY TYPE, LIFELINE CURVE
FIGURE 23 NORTH AMERICA Q-PCR REAGENTS MARKET: BY PLEXITY, 2021
FIGURE 24 NORTH AMERICA Q-PCR REAGENTS MARKET: BY PLEXITY, 2020-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA Q-PCR REAGENTS MARKET: BY PLEXITY, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA Q-PCR REAGENTS MARKET: BY PLEXITY, LIFELINE CURVE
FIGURE 27 NORTH AMERICA Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, 2021
FIGURE 28 NORTH AMERICA Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, 2020-2029 (USD MILLION)
FIGURE 29 NORTH AMERICA Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, LIFELINE CURVE
FIGURE 31 NORTH AMERICA Q-PCR REAGENTS MARKET: BY TECHNOLOGY, 2021
FIGURE 32 NORTH AMERICA Q-PCR REAGENTS MARKET: BY TECHNOLOGY, 2020-2029 (USD MILLION)
FIGURE 33 NORTH AMERICA Q-PCR REAGENTS MARKET: BY TECHNOLOGY, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA Q-PCR REAGENTS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 35 NORTH AMERICA Q-PCR REAGENTS MARKET: BY APPLICATION, 2021
FIGURE 36 NORTH AMERICA Q-PCR REAGENTS MARKET: BY APPLICATION, 2020-2029 (USD MILLION)
FIGURE 37 NORTH AMERICA Q-PCR REAGENTS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 38 NORTH AMERICA Q-PCR REAGENTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 39 NORTH AMERICA Q-PCR REAGENTS MARKET: BY END USER, 2021
FIGURE 40 NORTH AMERICA Q-PCR REAGENTS MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 41 NORTH AMERICA Q-PCR REAGENTS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 42 NORTH AMERICA Q-PCR REAGENTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 43 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 44 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 45 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 46 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 47 NORTH AMERICA Q-PCR REAGENTS MARKET: SNAPSHOT (2021)
FIGURE 48 NORTH AMERICA Q-PCR REAGENTS MARKET: BY COUNTRY (2021)
FIGURE 49 NORTH AMERICA Q-PCR REAGENTS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 50 NORTH AMERICA Q-PCR REAGENTS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 51 NORTH AMERICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE (2022-2029)
FIGURE 52 NORTH AMERICA Q-PCR REAGENTS MARKET: COMPANY SHARE 2021 (%)
